(Cancer Research UK) CANCER RESEARCH TECHNOLOGY (CRT) has signed a further deal with Merck, a leading science and technology company, to discover new cancer drugs targeting the Hippo pathway, today (Thursday).
from EurekAlert! - Social and Behavioral Science http://ift.tt/2tmVQcc
No comments:
Post a Comment